Jupiter Neurosciences, Inc. Common Stock (JUNS)

Jupiter Neurosciences, Inc. Common Stock (JUNS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.4M; returns 1 day +15.5%, 1 week +2.6%, 1 year -97.3%.

Jupiter Neurosciences, Inc. (NASDAQ: JUNS) is a clinical-stage pharmaceutical company focused on treating neuroinflammation through its proprietary resveratrol delivery platform, JOTROL™. The company's core technology is designed to significantly increase the bioavailability of resveratrol, a compound with potential therapeutic benefits for central nervous system (CNS) disorders.

Groups JUNS belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Biotechnology
• Pharmaceuticals
• Clinical Stage
• Neuroscience
• CNS Disorders
• Healthcare
• Rare Diseases
• Alzheimer's Disease
• Neurological Disorders

JUNS financial model: income statement, cash flow and balance sheet